Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Balance Sheets

v3.25.1
Condensed Consolidated Balance Sheets - USD ($)
Mar. 31, 2025
Dec. 31, 2024
Current assets:    
Cash $ 10,863,296 $ 9,601,298
Prepaid expenses and other current assets 920,472 473,834
Australia research and development incentives receivable 78,084 77,347
Total current assets 11,861,852 10,152,479
Other assets 2,800 2,800
Total assets 11,864,652 10,155,279
Current liabilities:    
Accounts payable 1,841,369 1,512,436
Accrued expenses 3,216,142 2,317,602
Total current liabilities 5,057,511 3,830,038
Long term liabilities:    
Warrant liability 1,864,616 2,690,605
Total liabilities 6,922,127 6,520,643
Commitments and contingencies (Note 7)
Stockholders' equity (deficit)    
Preferred stock, $0.0001 par value, 30,000,000 shares authorized at March 31, 2025 and December 31, 2024, 0 shares issued and outstanding
Common stock, $0.0001 par value, 70,000,000 shares authorized at March 31, 2025 and December 31, 2024, 29,587,314 and 26,157,788 shares issued and outstanding at March 31, 2025 and December 31, 2024, respectively 2,959 2,616
Additional paid-in capital 96,729,813 90,897,468
Accumulated deficit (91,752,092) (87,234,833)
Accumulated other comprehensive loss (38,155) (30,615)
Total stockholders' equity 4,942,525 3,634,636
Total liabilities and stockholders' equity $ 11,864,652 $ 10,155,279